HEADER TRANSFERASE/INHIBITOR 10-SEP-08 3EFW TITLE STRUCTURE OF AURORAA WITH PYRIDYL-PYRIMIDINE UREA INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 6; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: AURORA KINASE A, AURORA-A, SERINE/THREONINE KINASE 15, COMPND 5 AURORA/IPL1-RELATED KINASE 1, AURORA-RELATED KINASE 1, HARK1, BREAST COMPND 6 TUMOR-AMPLIFIED KINASE; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AURKA, AIK, ARK1, AURA, BTAK, STK15, STK6; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS AURORAA, STK6_HUMAN, ATP-BINDING, CELL CYCLE, KINASE, NUCLEOTIDE- KEYWDS 2 BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, KEYWDS 3 TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.F.BELLON,V.CEE,P.HUGHES,S.GEUNS-MEYER,D.WHITTINGTON REVDAT 4 21-FEB-24 3EFW 1 REMARK REVDAT 3 26-JUN-13 3EFW 1 JRNL REVDAT 2 21-MAR-12 3EFW 1 DBREF REMARK SEQRES VERSN REVDAT 2 2 1 KEYWDS HEADER REVDAT 1 23-DEC-08 3EFW 0 JRNL AUTH V.J.CEE,A.C.CHENG,K.ROMERO,S.BELLON,C.MOHR,D.A.WHITTINGTON, JRNL AUTH 2 A.BAK,J.BREADY,S.CAENEPEEL,A.COXON,H.L.DEAK,J.FRETLAND,Y.GU, JRNL AUTH 3 B.L.HODOUS,X.HUANG,J.L.KIM,J.LIN,A.M.LONG,H.NGUYEN, JRNL AUTH 4 P.R.OLIVIERI,V.F.PATEL,L.WANG,Y.ZHOU,P.HUGHES,S.GEUNS-MEYER JRNL TITL PYRIDYL-PYRIMIDINE BENZIMIDAZOLE DERIVATIVES AS POTENT, JRNL TITL 2 SELECTIVE, AND ORALLY BIOAVAILABLE INHIBITORS OF TIE-2 JRNL TITL 3 KINASE. JRNL REF BIOORG.MED.CHEM.LETT. V. 19 424 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19062275 JRNL DOI 10.1016/J.BMCL.2008.11.056 REMARK 2 REMARK 2 RESOLUTION. 2.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.63 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 85.2 REMARK 3 NUMBER OF REFLECTIONS : 20740 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.260 REMARK 3 R VALUE (WORKING SET) : 0.258 REMARK 3 FREE R VALUE : 0.295 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1110 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.29 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.35 REMARK 3 REFLECTION IN BIN (WORKING SET) : 793 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 44.70 REMARK 3 BIN R VALUE (WORKING SET) : 0.3100 REMARK 3 BIN FREE R VALUE SET COUNT : 33 REMARK 3 BIN FREE R VALUE : 0.5010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3846 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 60 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.37000 REMARK 3 B22 (A**2) : -1.36000 REMARK 3 B33 (A**2) : 2.73000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.581 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.318 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.239 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.704 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.903 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.875 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4025 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5465 ; 1.018 ; 1.994 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 476 ; 4.607 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 181 ;37.058 ;23.425 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 660 ;15.007 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;16.341 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 598 ; 0.059 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3062 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1657 ; 0.175 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2742 ; 0.298 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 153 ; 0.131 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 45 ; 0.183 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 11 ; 0.225 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2483 ; 0.432 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3856 ; 0.784 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1780 ; 0.854 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1609 ; 1.336 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3EFW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-SEP-08. REMARK 100 THE DEPOSITION ID IS D_1000049272. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAY-04 REMARK 200 TEMPERATURE (KELVIN) : 130 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22081 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.8 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.41 REMARK 200 COMPLETENESS FOR SHELL (%) : 60.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.31600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE, 0.4 M AMMONIUM REMARK 280 SULFATE, 15% PEG 4000, PH 4.6, VAPOR DIFFUSION, TEMPERATURE 273K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.87600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.87600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 59.25550 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 62.72400 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 59.25550 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 62.72400 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 37.87600 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 59.25550 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 62.72400 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 37.87600 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 59.25550 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 62.72400 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 125 REMARK 465 GLY A 276 REMARK 465 TRP A 277 REMARK 465 SER A 278 REMARK 465 VAL A 279 REMARK 465 HIS A 280 REMARK 465 ALA A 281 REMARK 465 PRO A 282 REMARK 465 SER A 283 REMARK 465 SER A 284 REMARK 465 ARG A 285 REMARK 465 ARG A 286 REMARK 465 THR A 287 REMARK 465 THR A 288 REMARK 465 LEU A 289 REMARK 465 CYS A 290 REMARK 465 GLY A 291 REMARK 465 THR A 292 REMARK 465 GLY A 303 REMARK 465 ARG A 304 REMARK 465 MET A 305 REMARK 465 HIS A 306 REMARK 465 ASP A 307 REMARK 465 GLU A 308 REMARK 465 LYS A 389 REMARK 465 PRO A 390 REMARK 465 SER A 391 REMARK 465 LYS B 125 REMARK 465 GLY B 276 REMARK 465 TRP B 277 REMARK 465 SER B 278 REMARK 465 VAL B 279 REMARK 465 HIS B 280 REMARK 465 ALA B 281 REMARK 465 PRO B 282 REMARK 465 SER B 283 REMARK 465 SER B 284 REMARK 465 ARG B 285 REMARK 465 ARG B 286 REMARK 465 THR B 287 REMARK 465 THR B 288 REMARK 465 LEU B 289 REMARK 465 CYS B 290 REMARK 465 GLY B 291 REMARK 465 THR B 292 REMARK 465 GLY B 303 REMARK 465 ARG B 304 REMARK 465 MET B 305 REMARK 465 HIS B 306 REMARK 465 ASP B 307 REMARK 465 PRO B 390 REMARK 465 SER B 391 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 126 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 143 CG CD CE NZ REMARK 470 ARG A 151 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 156 CG CD CE NZ REMARK 470 GLN A 177 CG CD OE1 NE2 REMARK 470 ARG A 179 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 181 CG CD OE1 OE2 REMARK 470 HIS A 248 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 250 CG CD CE NZ REMARK 470 ARG A 251 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 255 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 258 CG CD CE NZ REMARK 470 ASN A 332 CG OD1 ND2 REMARK 470 TYR A 334 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN A 335 CG CD OE1 NE2 REMARK 470 GLN B 127 CG CD OE1 NE2 REMARK 470 LYS B 143 CG CD CE NZ REMARK 470 LYS B 166 CG CD CE NZ REMARK 470 GLU B 170 CG CD OE1 OE2 REMARK 470 LYS B 171 CG CD CE NZ REMARK 470 ARG B 179 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 180 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 251 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 255 CG CD NE CZ NH1 NH2 REMARK 470 TYR B 334 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN B 335 CG CD OE1 NE2 REMARK 470 LYS B 389 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 407 O HOH A 444 3655 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 155 -5.34 -140.57 REMARK 500 ASP A 202 -137.33 -118.03 REMARK 500 SER A 226 -54.10 72.82 REMARK 500 ARG A 255 -133.77 -74.44 REMARK 500 ASP A 294 -16.90 -49.97 REMARK 500 LYS B 143 99.46 -65.94 REMARK 500 LEU B 159 -157.79 -143.58 REMARK 500 ASP B 202 -141.71 -122.29 REMARK 500 SER B 226 -45.55 76.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AK8 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AK8 B 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 405 DBREF 3EFW A 125 391 UNP O14965 STK6_HUMAN 125 391 DBREF 3EFW B 125 391 UNP O14965 STK6_HUMAN 125 391 SEQRES 1 A 267 LYS ARG GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY ARG SEQRES 2 A 267 PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU ALA SEQRES 3 A 267 ARG GLU LYS GLN SER LYS PHE ILE LEU ALA LEU LYS VAL SEQRES 4 A 267 LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU HIS SEQRES 5 A 267 GLN LEU ARG ARG GLU VAL GLU ILE GLN SER HIS LEU ARG SEQRES 6 A 267 HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS ASP SEQRES 7 A 267 ALA THR ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO LEU SEQRES 8 A 267 GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SER LYS PHE SEQRES 9 A 267 ASP GLU GLN ARG THR ALA THR TYR ILE THR GLU LEU ALA SEQRES 10 A 267 ASN ALA LEU SER TYR CYS HIS SER LYS ARG VAL ILE HIS SEQRES 11 A 267 ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU GLY SER ALA SEQRES 12 A 267 GLY GLU LEU LYS ILE ALA ASP PHE GLY TRP SER VAL HIS SEQRES 13 A 267 ALA PRO SER SER ARG ARG THR THR LEU CYS GLY THR LEU SEQRES 14 A 267 ASP TYR LEU PRO PRO GLU MET ILE GLU GLY ARG MET HIS SEQRES 15 A 267 ASP GLU LYS VAL ASP LEU TRP SER LEU GLY VAL LEU CYS SEQRES 16 A 267 TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA ASN SEQRES 17 A 267 THR TYR GLN GLU THR TYR LYS ARG ILE SER ARG VAL GLU SEQRES 18 A 267 PHE THR PHE PRO ASP PHE VAL THR GLU GLY ALA ARG ASP SEQRES 19 A 267 LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SER GLN ARG SEQRES 20 A 267 PRO MET LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE THR SEQRES 21 A 267 ALA ASN SER SER LYS PRO SER SEQRES 1 B 267 LYS ARG GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY ARG SEQRES 2 B 267 PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU ALA SEQRES 3 B 267 ARG GLU LYS GLN SER LYS PHE ILE LEU ALA LEU LYS VAL SEQRES 4 B 267 LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU HIS SEQRES 5 B 267 GLN LEU ARG ARG GLU VAL GLU ILE GLN SER HIS LEU ARG SEQRES 6 B 267 HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS ASP SEQRES 7 B 267 ALA THR ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO LEU SEQRES 8 B 267 GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SER LYS PHE SEQRES 9 B 267 ASP GLU GLN ARG THR ALA THR TYR ILE THR GLU LEU ALA SEQRES 10 B 267 ASN ALA LEU SER TYR CYS HIS SER LYS ARG VAL ILE HIS SEQRES 11 B 267 ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU GLY SER ALA SEQRES 12 B 267 GLY GLU LEU LYS ILE ALA ASP PHE GLY TRP SER VAL HIS SEQRES 13 B 267 ALA PRO SER SER ARG ARG THR THR LEU CYS GLY THR LEU SEQRES 14 B 267 ASP TYR LEU PRO PRO GLU MET ILE GLU GLY ARG MET HIS SEQRES 15 B 267 ASP GLU LYS VAL ASP LEU TRP SER LEU GLY VAL LEU CYS SEQRES 16 B 267 TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA ASN SEQRES 17 B 267 THR TYR GLN GLU THR TYR LYS ARG ILE SER ARG VAL GLU SEQRES 18 B 267 PHE THR PHE PRO ASP PHE VAL THR GLU GLY ALA ARG ASP SEQRES 19 B 267 LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SER GLN ARG SEQRES 20 B 267 PRO MET LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE THR SEQRES 21 B 267 ALA ASN SER SER LYS PRO SER HET AK8 A 404 36 HET SO4 A 405 5 HET AK8 B 404 36 HET SO4 B 405 5 HETNAM AK8 1-[3-METHYL-4-({3-[2-(METHYLAMINO)PYRIMIDIN-4- HETNAM 2 AK8 YL]PYRIDIN-2-YL}OXY)PHENYL]-3-[3-(TRIFLUOROMETHYL) HETNAM 3 AK8 PHENYL]UREA HETNAM SO4 SULFATE ION FORMUL 3 AK8 2(C25 H21 F3 N6 O2) FORMUL 4 SO4 2(O4 S 2-) FORMUL 7 HOH *60(H2 O) HELIX 1 1 ALA A 129 GLU A 131 5 3 HELIX 2 2 LYS A 166 GLY A 173 1 8 HELIX 3 3 VAL A 174 HIS A 187 1 14 HELIX 4 4 THR A 217 SER A 226 1 10 HELIX 5 5 ASP A 229 SER A 249 1 21 HELIX 6 6 LYS A 258 GLU A 260 5 3 HELIX 7 7 PRO A 297 ILE A 301 5 5 HELIX 8 8 LYS A 309 GLY A 325 1 17 HELIX 9 9 THR A 333 VAL A 344 1 12 HELIX 10 10 THR A 353 LEU A 364 1 12 HELIX 11 11 ASN A 367 ARG A 371 5 5 HELIX 12 12 MET A 373 GLU A 379 1 7 HELIX 13 13 HIS A 380 SER A 387 1 8 HELIX 14 14 ALA B 129 GLU B 131 5 3 HELIX 15 15 LYS B 166 GLY B 173 1 8 HELIX 16 16 VAL B 174 SER B 186 1 13 HELIX 17 17 THR B 217 SER B 226 1 10 HELIX 18 18 ASP B 229 SER B 249 1 21 HELIX 19 19 LYS B 258 GLU B 260 5 3 HELIX 20 20 PRO B 297 GLU B 302 1 6 HELIX 21 21 LYS B 309 GLY B 325 1 17 HELIX 22 22 THR B 333 ARG B 343 1 11 HELIX 23 23 THR B 353 LEU B 364 1 12 HELIX 24 24 ASN B 367 ARG B 371 5 5 HELIX 25 25 LEU B 374 GLU B 379 1 6 HELIX 26 26 HIS B 380 SER B 387 1 8 SHEET 1 A 5 PHE A 133 GLY A 142 0 SHEET 2 A 5 GLY A 145 GLU A 152 -1 O VAL A 147 N LEU A 139 SHEET 3 A 5 ILE A 158 PHE A 165 -1 O LEU A 159 N ALA A 150 SHEET 4 A 5 ARG A 205 LEU A 210 -1 O VAL A 206 N LEU A 164 SHEET 5 A 5 LEU A 196 HIS A 201 -1 N PHE A 200 O TYR A 207 SHEET 1 B 2 LEU A 262 LEU A 264 0 SHEET 2 B 2 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 SHEET 1 C 5 PHE B 133 GLY B 142 0 SHEET 2 C 5 GLY B 145 GLU B 152 -1 O VAL B 147 N LEU B 139 SHEET 3 C 5 ILE B 158 PHE B 165 -1 O LEU B 161 N TYR B 148 SHEET 4 C 5 ARG B 205 LEU B 210 -1 O VAL B 206 N LEU B 164 SHEET 5 C 5 LEU B 196 HIS B 201 -1 N PHE B 200 O TYR B 207 SHEET 1 D 2 LEU B 262 LEU B 264 0 SHEET 2 D 2 LEU B 270 ILE B 272 -1 O LYS B 271 N LEU B 263 SITE 1 AC1 15 LYS A 143 PHE A 144 VAL A 147 LYS A 162 SITE 2 AC1 15 VAL A 174 GLN A 177 LEU A 178 LEU A 210 SITE 3 AC1 15 GLU A 211 TYR A 212 ALA A 213 LEU A 263 SITE 4 AC1 15 ALA A 273 SO4 A 405 HOH A 416 SITE 1 AC2 4 ASN A 261 ASP A 274 PHE A 275 AK8 A 404 SITE 1 AC3 16 LYS B 143 VAL B 147 LYS B 162 VAL B 174 SITE 2 AC3 16 GLN B 177 LEU B 178 GLU B 181 LEU B 210 SITE 3 AC3 16 GLU B 211 ALA B 213 ASN B 261 LEU B 263 SITE 4 AC3 16 ALA B 273 PHE B 275 SO4 B 405 HOH B 414 SITE 1 AC4 3 ASP B 274 PHE B 275 AK8 B 404 CRYST1 118.511 125.448 75.752 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008438 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007971 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013201 0.00000